Logo image of ROGS.OL

ROGALAND SPAREBANK (ROGS.OL) Stock Fundamental Analysis

OSL:ROGS - Euronext Oslo - NO0006001007 - Common Stock - Currency: NOK

130.2  +0.2 (+0.15%)

Fundamental Rating

3

Overall ROGS gets a fundamental rating of 3 out of 10. We evaluated ROGS against 95 industry peers in the Banks industry. ROGS may be in some trouble as it scores bad on both profitability and health. ROGS is valied quite expensively at the moment, while it does show a decent growth rate. ROGS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ROGS was profitable.
ROGS had a negative operating cash flow in the past year.
Each year in the past 5 years ROGS has been profitable.
ROGS had negative operating cash flow in 4 of the past 5 years.
ROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

ROGS has a Return On Assets (0.86%) which is in line with its industry peers.
ROGS has a Return On Equity of 8.02%. This is comparable to the rest of the industry: ROGS outperforms 46.32% of its industry peers.
Industry RankSector Rank
ROA 0.86%
ROE 8.02%
ROIC N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.81%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROGS.OL Yearly ROA, ROE, ROICROGS.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

Looking at the Profit Margin, with a value of 28.86%, ROGS is in the better half of the industry, outperforming 77.89% of the companies in the same industry.
In the last couple of years the Profit Margin of ROGS has remained more or less at the same level.
The Operating Margin and Gross Margin are not available for ROGS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 28.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.15%
PM growth 5Y0.02%
GM growth 3YN/A
GM growth 5YN/A
ROGS.OL Yearly Profit, Operating, Gross MarginsROGS.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

ROGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ROGS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ROGS has less shares outstanding
ROGS has a better debt/assets ratio than last year.
ROGS.OL Yearly Shares OutstandingROGS.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ROGS.OL Yearly Total Debt VS Total AssetsROGS.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

A Debt/Equity ratio of 4.14 is on the high side and indicates that ROGS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.14, ROGS is doing worse than 81.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.95%
ROGS.OL Yearly LT Debt VS Equity VS FCFROGS.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ROGS.OL Yearly Current Assets VS Current LiabilitesROGS.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

ROGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
The Earnings Per Share has been growing by 10.81% on average over the past years. This is quite good.
The Revenue has grown by 51.05% in the past year. This is a very strong growth!
Measured over the past years, ROGS shows a quite strong growth in Revenue. The Revenue has been growing by 9.48% on average per year.
EPS 1Y (TTM)32%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%19.05%
Revenue 1Y (TTM)51.05%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%17.87%

3.2 Future

ROGS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.27% yearly.
ROGS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.96% yearly.
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue Next Year2.88%
Revenue Next 2Y2%
Revenue Next 3Y1.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ROGS.OL Yearly Revenue VS EstimatesROGS.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ROGS.OL Yearly EPS VS EstimatesROGS.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

ROGS is valuated reasonably with a Price/Earnings ratio of 9.86.
ROGS's Price/Earnings is on the same level as the industry average.
ROGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.10.
The Price/Forward Earnings ratio is 10.58, which indicates a very decent valuation of ROGS.
ROGS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ROGS is more expensive than 62.11% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ROGS to the average of the S&P500 Index (20.74), we can say ROGS is valued slightly cheaper.
Industry RankSector Rank
PE 9.86
Fwd PE 10.58
ROGS.OL Price Earnings VS Forward Price EarningsROGS.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROGS.OL Per share dataROGS.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

ROGS's earnings are expected to decrease with -2.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.37%, ROGS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.30, ROGS pays a better dividend. On top of this ROGS pays more dividend than 86.32% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.43, ROGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.37%

5.2 History

The dividend of ROGS is nicely growing with an annual growth rate of 16.29%!
Dividend Growth(5Y)16.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

71.05% of the earnings are spent on dividend by ROGS. This is not a sustainable payout ratio.
ROGS's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.05%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
ROGS.OL Yearly Income VS Free CF VS DividendROGS.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
ROGS.OL Dividend Payout.ROGS.OL Dividend Payout, showing the Payout Ratio.ROGS.OL Dividend Payout.PayoutRetained Earnings

ROGALAND SPAREBANK

OSL:ROGS (5/5/2025, 7:00:00 PM)

130.2

+0.2 (+0.15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners30.64%
Inst Owner ChangeN/A
Ins Owners6.82%
Ins Owner ChangeN/A
Market Cap3.26B
Analysts80
Price Target145.52 (11.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.37%
Yearly Dividend11.09
Dividend Growth(5Y)16.29%
DP71.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.96%
Min EPS beat(2)8.29%
Max EPS beat(2)63.64%
EPS beat(4)3
Avg EPS beat(4)18.46%
Min EPS beat(4)-2.31%
Max EPS beat(4)63.64%
EPS beat(8)4
Avg EPS beat(8)12.88%
EPS beat(12)6
Avg EPS beat(12)7.16%
EPS beat(16)9
Avg EPS beat(16)10.67%
Revenue beat(2)1
Avg Revenue beat(2)8.11%
Min Revenue beat(2)-6.12%
Max Revenue beat(2)22.35%
Revenue beat(4)2
Avg Revenue beat(4)4.29%
Min Revenue beat(4)-6.12%
Max Revenue beat(4)22.35%
Revenue beat(8)4
Avg Revenue beat(8)5.19%
Revenue beat(12)6
Avg Revenue beat(12)5.28%
Revenue beat(16)10
Avg Revenue beat(16)4.56%
PT rev (1m)0.71%
PT rev (3m)1.18%
EPS NQ rev (1m)-14.15%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.49%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.58
P/S 2.74
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)13.2
EY10.14%
EPS(NY)12.31
Fwd EY9.45%
FCF(TTM)-20.26
FCFYN/A
OCF(TTM)-20.23
OCFYN/A
SpS47.48
BVpS170.8
TBVpS170.58
PEG (NY)N/A
PEG (5Y)0.91
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 8.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.86%
GM N/A
FCFM N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.81%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.15%
PM growth 5Y0.02%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC5.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%19.05%
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue 1Y (TTM)51.05%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%17.87%
Revenue Next Year2.88%
Revenue Next 2Y2%
Revenue Next 3Y1.96%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-262.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-264.21%
OCF growth 3YN/A
OCF growth 5YN/A